Literature DB >> 23912621

Real-time monitoring of radiofrequency ablation and postablation assessment: accuracy of contrast-enhanced US in experimental rat liver model.

Hanping Wu1, Luke R Wilkins, Nicholas P Ziats, John R Haaga, Agata A Exner.   

Abstract

PURPOSE: To examine the accuracy of the unenhanced zone at contrast material-enhanced ultrasonography (US) in predicting coagulative necrosis during and 21 days after radiofrequency (RF) ablation by using radiologic-pathologic comparison.
MATERIALS AND METHODS: Animal studies were approved by the Institutional Animal Care and Use Committee. The livers of 28 rats underwent US-guided RF ablation. In four animals, contrast-enhanced US was performed during ablation and 2 hours and 2, 7, 14, and 21 days after ablation. The unenhanced zone area on US images was measured. DiI-labeled microbubbles were administered during ablation at 2, 4, and 6 minutes or at 2 hours and 2, 7, 14, and 21 days after ablation in the remaining 24 animals (n = 3 at each time point). One minute later, the animal was euthanized, and the ablated liver was harvested. Tissue samples were imaged to quantify total fluorescence, and NADH staining was performed on the same slice. Hematoxylin-eosin staining was also performed. The findings on fluorescence images, NADH-stained images, and hematoxylin-eosin-stained images were compared. The areas of DiI bubble-negative zones, NADH-negative zones, and lightly NADH-staining zones were measured. Data were analyzed by using one-way analysis of variance.
RESULTS: The area of the unenhanced zone on contrast-enhanced US images increased during RF ablation and reached a maximum within 2 days after ablation. At histopathologic examination, a transition zone manifested adjacent to the coagulation zone until 2 days after ablation. The DiI-bubble negative zone on fluorescence images and the damaged zone (transition zone plus coagulation zone) on NADH-stained images increased rapidly within 2 hours after ablation, then slowly reached the maximum on day 2. The ratios of the mean areas of these two zones at hour 2 to those at day 2 were 94.6% and 95.6%, respectively. High uniformity between the damaged zone on NADH-stained images and the DiI bubble-negative zone on fluorescence images was noted at all time points.
CONCLUSION: The temporary transition zone in NADH staining is partially damaged and should transition to nonviability 2 days after ablation. These results demonstrate that contrast-enhanced US can help delineate the maximum area of cell damage (to within 5% of the maximum) as early as 2 hours after ablation. Contrast-enhanced US may be a simple and accurate tool for monitoring the effects of RF ablation and quantifying the size of thermal damage after treatment. © RSNA, 2013.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23912621      PMCID: PMC4228713          DOI: 10.1148/radiol.13121999

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  27 in total

1.  MR monitoring of tumour thermal therapy.

Authors:  D Germain; P Chevallier; A Laurent; H Saint-Jalmes
Journal:  MAGMA       Date:  2001-08       Impact factor: 2.310

2.  Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography.

Authors:  Hitoshi Maruyama; Masanori Takahashi; Hiroyuki Ishibashi; Hidehiro Okugawa; Shinichiro Okabe; Masaharu Yoshikawa; Osamu Yokosuka
Journal:  Liver Int       Date:  2008-09-18       Impact factor: 5.828

Review 3.  Contrast echocardiography in critical care: echoes of the future? A review of the role of microsphere contrast echocardiography.

Authors:  David G Platts; John F Fraser
Journal:  Crit Care Resusc       Date:  2011-03       Impact factor: 2.159

Review 4.  Radiofrequency ablation of liver tumors: the role of microbubble ultrasound contrast agents.

Authors:  Maria Franca Meloni; Tito Livraghi; Carlo Filice; Sergio Lazzaroni; Fabrizio Calliada; Leonardo Perretti
Journal:  Ultrasound Q       Date:  2006-03       Impact factor: 1.657

5.  Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.

Authors:  S A Curley; F Izzo; L M Ellis; J Nicolas Vauthey; P Vallone
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

6.  Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

Authors:  T Livraghi; S N Goldberg; S Lazzaroni; F Meloni; T Ierace; L Solbiati; G S Gazelle
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

7.  Lesion progression with time and the effect of vascular occlusion following radiofrequency ablation of the liver.

Authors:  W J Wiersinga; M C Jansen; I H Straatsburg; P H Davids; J M Klaase; D J Gouma; T M van Gulik
Journal:  Br J Surg       Date:  2003-03       Impact factor: 6.939

8.  Formulation and characterization of echogenic lipid-Pluronic nanobubbles.

Authors:  Tianyi M Krupka; Luis Solorio; Robin E Wilson; Hanping Wu; Nami Azar; Agata A Exner
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

9.  Radiofrequency ablation: post-ablation assessment using CT perfusion with pharmacological modulation in a rat subcutaneous tumor model.

Authors:  Hanping Wu; Agata A Exner; Tianyi M Krupka; Brent D Weinberg; Ravi Patel; John R Haaga
Journal:  Acad Radiol       Date:  2009-03       Impact factor: 3.173

10.  Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response.

Authors:  Masao Akeboshi; Koichiro Yamakado; Atsuhiro Nakatsuka; Osamu Hataji; Osamu Taguchi; Motoshi Takao; Kan Takeda
Journal:  J Vasc Interv Radiol       Date:  2004-05       Impact factor: 3.464

View more
  21 in total

1.  Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.

Authors:  Xiao-Wan Bo; Hui-Xiong Xu; Le-Hang Guo; Li-Ping Sun; Xiao-Long Li; Chong-Ke Zhao; Ya-Ping He; Bo-Ji Liu; Dan-Dan Li; Kun Zhang; Dan Wang
Journal:  Br J Radiol       Date:  2017-07-27       Impact factor: 3.039

2.  2D shear-wave ultrasound elastography (SWE) evaluation of ablation zone following radiofrequency ablation of liver lesions: is it more accurate?

Authors:  Xiao W Bo; Xiao L Li; Hui X Xu; Le H Guo; Dan D Li; Bo J Liu; Dan Wang; Ya P He; Xiao H Xu
Journal:  Br J Radiol       Date:  2016       Impact factor: 3.039

3.  Clinical evaluation of in silico planning and real-time simulation of hepatic radiofrequency ablation (ClinicIMPPACT Trial).

Authors:  Michael Moche; Harald Busse; Jurgen J Futterer; Camila A Hinestrosa; Daniel Seider; Philipp Brandmaier; Marina Kolesnik; Sjoerd Jenniskens; Roberto Blanco Sequeiros; Gaber Komar; Mika Pollari; Martin Eibisberger; Horst Rupert Portugaller; Philip Voglreiter; Ronan Flanagan; Panchatcharam Mariappan; Martin Reinhardt
Journal:  Eur Radiol       Date:  2019-08-30       Impact factor: 5.315

4.  Chronological changes of radiofrequency ablation zone in rabbit liver: an in vivo correlation between gross pathology and histopathology.

Authors:  Kyoung D Song; Min Woo Lee; Hyunchul Rhim; Tae Wook Kang; Dong Ik Cha; Jehoon Yang
Journal:  Br J Radiol       Date:  2017-01-31       Impact factor: 3.039

5.  Bipolar radiofrequency ablation for liver tumors: comparison of contrast-enhanced ultrasound with contrast-enhanced MRI/CT in the posttreatment imaging evaluation.

Authors:  Xiao-Wan Bo; Hui-Xiong Xu; Li-Ping Sun; Shu-Guang Zheng; Le-Hang Guo; Feng Lu; Jian Wu; Xiao-Hong Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

6.  Radiofrequency and microwave ablation in a porcine liver model: non-contrast CT and ultrasound radiologic-pathologic correlation.

Authors:  Timothy J Ziemlewicz; J Louis Hinshaw; Meghan G Lubner; Emily A Knott; Bridgett J Willey; Fred T Lee; Christopher L Brace
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

7.  Time-intensity-curve Analysis and Tumor Extravasation of Nanobubble Ultrasound Contrast Agents.

Authors:  Hanping Wu; Eric C Abenojar; Reshani Perera; Al Christopher De Leon; Tianzhi An; Agata A Exner
Journal:  Ultrasound Med Biol       Date:  2019-06-24       Impact factor: 2.998

8.  Three-dimensional quantitative assessment of ablation margins based on registration of pre- and post-procedural MRI and distance map.

Authors:  Soichiro Tani; Servet Tatli; Nobuhiko Hata; Xavier Garcia-Rojas; Olutayo I Olubiyi; Stuart G Silverman; Junichi Tokuda
Journal:  Int J Comput Assist Radiol Surg       Date:  2016-04-02       Impact factor: 2.924

9.  Percutaneous Laser Ablation of Unifocal Papillary Thyroid Microcarcinoma: Utility of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Assessing Local Therapeutic Response.

Authors:  Lu Zhang; Wei Zhou; Weiwei Zhan; Yan Peng; Shan Jiang; Shangyan Xu
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

10.  Interventional Optical Imaging Permits Instant Visualization of Pathological Zones of Ablated Tumor Periphery and Residual Tumor Detection.

Authors:  Xuefeng Kan; Guanhui Zhou; Feng Zhang; Hongxiu Ji; Hui Zheng; Jeffrey Forris Beecham Chick; Karim Valji; Chuansheng Zheng; Xiaoming Yang
Journal:  Cancer Res       Date:  2021-07-08       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.